- Home
- FNWD vs GNLX Comparison
FNWD vs GNLX Comparison
Compare FNWD & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNWD
- GNLX
- Stock Information
- Founded
- FNWD 1994
- GNLX 2001
- Country
- FNWD United States
- GNLX United States
- Employees
- FNWD N/A
- GNLX N/A
- Industry
- FNWD Savings Institutions
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- FNWD Finance
- GNLX Health Care
- Exchange
- FNWD Nasdaq
- GNLX Nasdaq
- Market Cap
- FNWD 143.6M
- GNLX 128.0M
- IPO Year
- FNWD N/A
- GNLX 2023
- Fundamental
- Price
- FNWD $33.12
- GNLX $7.38
- Analyst Decision
- FNWD Buy
- GNLX Strong Buy
- Analyst Count
- FNWD 1
- GNLX 5
- Target Price
- FNWD $34.00
- GNLX $17.40
- AVG Volume (30 Days)
- FNWD 25.6K
- GNLX 221.8K
- Earning Date
- FNWD 10-24-2025
- GNLX 11-13-2025
- Dividend Yield
- FNWD 1.46%
- GNLX N/A
- EPS Growth
- FNWD N/A
- GNLX N/A
- EPS
- FNWD 1.24
- GNLX N/A
- Revenue
- FNWD $63,780,000.00
- GNLX N/A
- Revenue This Year
- FNWD N/A
- GNLX N/A
- Revenue Next Year
- FNWD $7.77
- GNLX N/A
- P/E Ratio
- FNWD $26.47
- GNLX N/A
- Revenue Growth
- FNWD N/A
- GNLX N/A
- 52 Week Low
- FNWD $26.12
- GNLX $1.99
- 52 Week High
- FNWD $34.40
- GNLX $8.27
- Technical
- Relative Strength Index (RSI)
- FNWD 61.80
- GNLX 71.76
- Support Level
- FNWD $32.82
- GNLX $7.05
- Resistance Level
- FNWD $34.40
- GNLX $8.26
- Average True Range (ATR)
- FNWD 1.03
- GNLX 0.66
- MACD
- FNWD 0.06
- GNLX 0.18
- Stochastic Oscillator
- FNWD 66.04
- GNLX 74.47
About FNWD Finward Bancorp
Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.